	Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study. Eur J Cancer Bernard-Tessier A, Spanggaard I, Utriainen T, Tanner M, Rohrberg K, Naoun N, Ikonen T, Pohjanjousi P, Garratt C, Poehlein C, Fizazi K. PMID: 42777289 [PubMed - as supplied by publisher]
	Long-term outcomes and prognostic factors in pediatric Wilms tumor: a 47-year single-center experience. Turk J Pediatr Dinçer OS, Uygun A, Da, Ö, Kartal . PMID: 42777193 [PubMed - indexed for MEDLINE]
	Upfront Biparametric MRI for Prostate Cancer Screening: Experience in 618 Korean Men Outside of a Clinical Trial Setting. AJR Am J Roentgenol Joo Y, Tse JR, Yoon J, Jung DC, Oh YT, Park JH. PMID: 42776580 [PubMed - as supplied by publisher]
	GLG1 in cancer-associated fibroblasts promotes bladder cancer growth while limiting tumor apoptosis. Apoptosis Liu J, Zhou Z, Zhang B, Liu R, Zhang Y. PMID: 42776300 [PubMed - indexed for MEDLINE]
	Gut-prostate axis in prostate cancer: microbiome signatures, mechanistic insights, and therapeutic opportunities. Front Cell Infect Microbiol Wang K, Tang Q, Fan W, Su Q. PMID: 42775139 [PubMed - indexed for MEDLINE]
	Comparing diagnostic prostate cancer biomarkers using a framework of clinically meaningful criteria. BJUI Compass Wang S, Nabavizadeh B, Ramaswamy A, Davuluri M, Zhang TR, Tzeng M, Feiertag N, Hu JC. PMID: 42774974 [PubMed]
	Tertiary lymphoid structures in urothelial carcinoma: bridging spatial architecture with therapeutic vulnerability in the post-BCG era. Front Immunol Wei X, Pei X, Yu S. PMID: 42774854 [PubMed - indexed for MEDLINE]
	Correction to "Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)". BJU Int PMID: 42773819 [PubMed - as supplied by publisher]
	Timing of Radiographic Progression Relative to Prostate-Specific Antigen Kinetics in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving Upfront Androgen Receptor Signaling Inhibitor Therapy. Urol J Nakayama A, Ikezoe E, Inoue M, Tsujioka H, Nirazuka A, Izumi K, Setoguchi K, Saito K. PMID: 42773770 [PubMed - indexed for MEDLINE]
	Ileum vs Colon for Neobladder Reconstruction After Radical Cystectomy: A Systematic Review and Meta-Analysis. Urol J Li Y, Liu Y. PMID: 42773766 [PubMed - indexed for MEDLINE]
	Epidermoid Cyst of the Ureter Mimicking Recurrent Urothelial Carcinoma: A Case Report and Brief Literature Review. Am J Case Rep Halalsheh OM, Hulliel AF, Abualasal A, Aldeqes MI, Obeid A, Sharayah M, Al-Khatib S. PMID: 42773630 [PubMed - indexed for MEDLINE]
	Associations of Anatomical Location and Reader Experience With the Diagnostic Performance of Multiparametric MRI-Derived VI-RADS for Muscle Invasive Bladder Cancer: A Multicenter Multireader Study. J Magn Reson Imaging Wang X, Sun F, Hu J, Huang X, Du S, Wen Z, Lin F. PMID: 42773621 [PubMed - as supplied by publisher]
	Editorial for "Associations of Anatomical Location and Reader Experience With the Diagnostic Performance of Multiparametric MRI-Derived VI-RADS for Muscle Invasive Bladder Cancer: A Multicenter Multireader Study". J Magn Reson Imaging Ueno Y, Sofue K, Murakami T. PMID: 42773585 [PubMed - as supplied by publisher]
	Matrine induces aggressive prostate cancer cell death via inhibition of PPARÎ± activity: insights from transcriptomics, molecular docking, and functional studies. Exp Cell Res Wang X, Gu H, Tong Y, Gao H, Zhang L, Peng X, Xu X, Miao Y. PMID: 42772663 [PubMed - as supplied by publisher]
	Association of robot-assisted radical prostatectomy with improved oncological outcomes in patients with oligometastatic prostate cancer: A multicenter exploratory study in China. Urol Oncol Dong Y, Tian Z, Chen W, Li Z, Chen Z, Hu J, Fu B, Xu X, Zhang X, Wang B. PMID: 42772021 [PubMed - as supplied by publisher]
	A recurrent cancer-associated fibroblast/TGF-beta/endothelial barrier direction is associated with immune exclusion and checkpoint resistance in bladder cancer: a public multi-cohort transcriptomic study. PLoS One Wu Y, Li G, Jiang L, Zhang C, Fang H, Fan H. PMID: 42771603 [PubMed - indexed for MEDLINE]
	Evaluation of thulium laser endoscopic en bloc resection versus conventional trans-urethral en bloc resection of primary non-muscle invasive bladder cancer: a randomized controlled trial. Int Urol Nephrol Zaza MM, ElAzab ME, Ebskharoun SF, Salem TAM, Ali MH, Mousa W. PMID: 42771231 [PubMed - as supplied by publisher]
	Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry. Support Care Cancer Solberg A, Grydeland M, Nilsen TS, Storås AH, Davis ID, Greaves N, Anderson S, Fay AP, Chi KN, Enting D, McDermott R, Badal S, Waihenya CG, Popoola A, Lazarus JM, Mateo J, Bjartell A, Omlin A, Odedina F, Ragin C, Mucci LA, Russnes KM, IRONMAN investigators. PMID: 42771055 [PubMed - indexed for MEDLINE]
	[Current diagnostic and treatment practices for different stages of prostate cancer-real-world data from aÂ nationwide survey by the German Society for Immuno- and Targeted Therapy (DGFIT)]. Urologie Hegele A, Doehn C, Varga Z, Wagner U, Noessner E, Hübner A, Heinzer H, Siebels M. PMID: 42771044 [PubMed - as supplied by publisher]
	Theranostics in the management of prostate cancer: from concept to clinical practice. Expert Rev Clin Pharmacol Sridharan K, Alonso-Gordoa T, Sivaramakrishnan G, Cerrillo JM, Fiala O, Rehan F, Mena Cortes D, Santeoni M. PMID: 42770599 [PubMed - as supplied by publisher]

Articles 1 - 20 / 181639

Page 1 of 9082



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy